Let it be known: Massachusetts just sent a message to every state in America. The message couldn’t be clearer:
Regulated cannabis isn’t going anywhere.
$MSOS @TheDalesReport
To help clear up the confusion, Eric Berlin will join us on tomorrow’s livestream to answer some of the questions the cannabis industry has been asking all weekend.
@V_arrell@TheDalesReport $MSOS
⚖️ "The 21st is a week from today, so it's a Wednesday. I mean, that Wednesday afternoon or Thursday, he could say, 'I've considered this. I am granting the motion to admit the GAO report.' I'm a smart man. I can read of it what it is and apply it as I deem fit, and I'm therefore denying the motion to open the record for additional discovery. Now, maybe Shadd, what he does is say, 'I want one more brief. I want the opponents to submit a reply to the government's response on discovery.' That's possible. He gives them another week to do that. I think it's also possible that he rules pretty quickly."
— Eric Berlin, @Dentons Cannabis Attorney
🎦 WATCH the full interview: https://t.co/H9qzLJekA2
🌿 Cannabis ETFs: 🌎 $YOLO 🇺🇸 $MSOS
🔥-analysis: The DEA is fine including the GAO report (on process gaps) in the rescheduling hearing record but opposes extra briefings.
IMPACT: Rescheduling stays on track substantively. DEA still backs Schedule III; the separate medical marijuana Schedule III order is unaffected.
Now the judge must decide whether to:
1) Simply admit the GAO report (minimal delay)
2) Allow supplemental briefing (weeks)
3) Reopen for discovery/testimony (potentially months).
Any of the broader options (option #2 & option #3) pushes a final ALJ recommendation (and subsequent DEA administrator decision) further out.
Option #1 (best case scenario) seems the most likely outcome.
🌿 Cannabis ETFs: 🌎 $YOLO 🇺🇸 $MSOS
https://t.co/UL5U5uSaYh
🗞️ Green Thumb Industries Announces $50 Million Share Repurchase Program
@GTIGrows $GTBIF
🗣️ Ben Kovler @Bkov9, Green Thumb Founder, Chairman and CEO:
"Since launching our first repurchase program in 2023, we have returned more than $200 million to shareholders through share buybacks, including more than $80 million in 2026. As we continue to evaluate the best uses of our capital — from investing in organic growth to pursuing M&A opportunities — renewing this program gives us the flexibility to continue buying back stock when conditions present an attractive opportunity."
🌿 Cannabis ETFs: 🌎 $YOLO 🇺🇸 $MSOS
https://t.co/c4MbmroMZf